Tamoxifen Citrate Tablet
Product Images NDC 0378-0144

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tamoxifen Citrate (NDC 0378-0144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tamoxifen Structural Formula (2378410a 1b92 4e4c Af3f F8f75fa70aaf 01)

Chemical structure of Tamoxifen Citrate showing the molecular arrangement and formula with atoms and bonds labeled, including the citrate component.*

FDA Label Image

Image 01

Tamoxifen Citrate 10 mg oral tablets, USP, in a bottle label by Mylan Pharmaceuticals Inc. The label indicates 60 tablets per bottle with prescription-only status. It includes storage instructions to keep medication in a tightly closed, light-resistant container at 20° to 25°C and warnings to keep out of reach of children and avoid excessive heat.*

FDA Label Image

Image 02

Tamoxifen Citrate 20 mg tablets in a package label from Mylan Pharmaceuticals Inc. The label indicates the dosage strength of 20 mg per tablet and contains 30 tablets. It includes storage instructions, dispensing guidance, and a note that it is prescription only. The label features the NDC number 0378-0274-93 and Mylan branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.